Filing Details

Accession Number:
0001209191-11-051260
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-07 18:25:11
Reporting Period:
2011-10-05
Filing Date:
2011-10-07
Accepted Time:
2011-10-07 18:25:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219503 Mark Pulido P.o. Box 1334
Rancho Santa Fe CA 92067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-05 8,600 $5.08 23,530 No 4 M Direct
Common Stock Disposition 2011-10-05 8,600 $17.02 14,930 No 4 S Direct
Common Stock Acquisiton 2011-10-06 17,000 $5.08 31,930 No 4 M Direct
Common Stock Disposition 2011-10-06 17,000 $17.03 14,930 No 4 S Direct
Common Stock Acquisiton 2011-10-07 10,670 $5.08 25,600 No 4 M Direct
Common Stock Disposition 2011-10-07 10,670 $17.04 14,930 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Options Disposition 2011-10-05 8,600 $0.00 8,600 $5.08
Common Stock Non-Qualified Stock Options Disposition 2011-10-06 17,000 $0.00 17,000 $5.08
Common Stock Non-Qualified Stock Options Disposition 2011-10-07 10,670 $0.00 10,670 $5.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,400 2003-08-21 2012-08-21 No 4 M Direct
14,400 2006-08-21 2012-08-21 No 4 M Direct
3,730 2006-08-21 2012-08-21 No 4 M Direct
Footnotes
  1. All of the transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
  2. The weighted average purchase price for these transactions was $17.0176 per share, with a range of $17.00 to $17.11 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  3. The weighted average purchase price for these transactions was $17.0266 per share, with a range of $17.00 to $17.15 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
  4. The weighted average purchase price for these transactions was $17.0407 per share, with a range of $17.00 to $17.1243 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.